Global Psoriasis Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024

  • ID:PD035914
  • September 2019
  • GIR (Global Info Research)
                          

The Global Psoriasis Drugs Market Report is equipped with market data from 2014 to 2024. The report gives a market overview covering key drivers and risks factors. The report is bifurcated by top global manufactures mentioning sales, revenue and prices as applicable. It also evaluates the competitive scenario of the leading players. The report expands to cover regional market data along with type and application. The report forecasts sales and revenue from 2019 to 2024. The detailed sales channel is also covered in the study.

Scope of the Report:
Psoriasis is a genetic condition that may not be present at birth. The condition may be triggered by certain environmental and genetic factors. Changing lifestyles of people are leading to increased alcohol consumption and smoking, unhealthy diet, and sedentary living, which makes people more prone to this condition.
The global Psoriasis Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Psoriasis Drugs.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Psoriasis Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Psoriasis Drugs market by product type and applications/end industries.

Market Segment by Companies, this report covers

  •     AbbVie
  •     Amgen
  •     Johnson & Johnson
  •     Novartis
  •     Eli Lilly & Company
  •     AstraZeneca
  •     Celgene Corporation
  •     UCB
  •     Merck

Market Segment by Regions, regional analysis covers
  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, UK, Russia and Italy)
  • Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • South America (Brazil, Argentina, Colombia)
  • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
  •     Tumor Necrosis Factor Inhibitor
  •     Interleukin Inhibitors
  •     Others

Market Segment by Applications, can be divided into
  •     Topicals
  •     Systemic
  •     Biologics

Table of Contents

1 Psoriasis Drugs Market Overview
    1.1 Product Overview and Scope of Psoriasis Drugs
    1.2 Classification of Psoriasis Drugs by Types
        1.2.1 Global Psoriasis Drugs Revenue Comparison by Types (2019-2024)
        1.2.2 Global Psoriasis Drugs Revenue Market Share by Types in 2018
        1.2.3 Tumor Necrosis Factor Inhibitor
        1.2.4 Interleukin Inhibitors
        1.2.5 Others
    1.3 Global Psoriasis Drugs Market by Application
        1.3.1 Global Psoriasis Drugs Market Size and Market Share Comparison by Applications (2014-2024)
        1.3.2 Topicals
        1.3.3 Systemic
        1.3.4 Biologics
    1.4 Global Psoriasis Drugs Market by Regions
        1.4.1 Global Psoriasis Drugs Market Size (Million USD) Comparison by Regions (2014-2024)
        1.4.1 North America (USA, Canada and Mexico) Psoriasis Drugs Status and Prospect (2014-2024)
        1.4.2 Europe (Germany, France, UK, Russia and Italy) Psoriasis Drugs Status and Prospect (2014-2024)
        1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Psoriasis Drugs Status and Prospect (2014-2024)
        1.4.4 South America (Brazil, Argentina, Colombia) Psoriasis Drugs Status and Prospect (2014-2024)
        1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Psoriasis Drugs Status and Prospect (2014-2024)
    1.5 Global Market Size of Psoriasis Drugs (2014-2024)
2 Manufacturers Profiles
    2.1 AbbVie
        2.1.1 Business Overview
        2.1.2 Psoriasis Drugs Type and Applications
            2.1.2.1 Product A
            2.1.2.2 Product B
        2.1.3 AbbVie Psoriasis Drugs Revenue, Gross Margin and Market Share (2017-2018)
    2.2 Amgen
        2.2.1 Business Overview
        2.2.2 Psoriasis Drugs Type and Applications
            2.2.2.1 Product A
            2.2.2.2 Product B
        2.2.3 Amgen Psoriasis Drugs Revenue, Gross Margin and Market Share (2017-2018)
    2.3 Johnson & Johnson
        2.3.1 Business Overview
        2.3.2 Psoriasis Drugs Type and Applications
            2.3.2.1 Product A
            2.3.2.2 Product B
        2.3.3 Johnson & Johnson Psoriasis Drugs Revenue, Gross Margin and Market Share (2017-2018)
    2.4 Novartis
        2.4.1 Business Overview
        2.4.2 Psoriasis Drugs Type and Applications
            2.4.2.1 Product A
            2.4.2.2 Product B
        2.4.3 Novartis Psoriasis Drugs Revenue, Gross Margin and Market Share (2017-2018)
    2.5 Eli Lilly & Company
        2.5.1 Business Overview
        2.5.2 Psoriasis Drugs Type and Applications
            2.5.2.1 Product A
            2.5.2.2 Product B
        2.5.3 Eli Lilly & Company Psoriasis Drugs Revenue, Gross Margin and Market Share (2017-2018)
    2.6 AstraZeneca
        2.6.1 Business Overview
        2.6.2 Psoriasis Drugs Type and Applications
            2.6.2.1 Product A
            2.6.2.2 Product B
        2.6.3 AstraZeneca Psoriasis Drugs Revenue, Gross Margin and Market Share (2017-2018)
    2.7 Celgene Corporation
        2.7.1 Business Overview
        2.7.2 Psoriasis Drugs Type and Applications
            2.7.2.1 Product A
            2.7.2.2 Product B
        2.7.3 Celgene Corporation Psoriasis Drugs Revenue, Gross Margin and Market Share (2017-2018)
    2.8 UCB
        2.8.1 Business Overview
        2.8.2 Psoriasis Drugs Type and Applications
            2.8.2.1 Product A
            2.8.2.2 Product B
        2.8.3 UCB Psoriasis Drugs Revenue, Gross Margin and Market Share (2017-2018)
    2.9 Merck
        2.9.1 Business Overview
        2.9.2 Psoriasis Drugs Type and Applications
            2.9.2.1 Product A
            2.9.2.2 Product B
        2.9.3 Merck Psoriasis Drugs Revenue, Gross Margin and Market Share (2017-2018)
3 Global Psoriasis Drugs Market Competition, by Players
    3.1 Global Psoriasis Drugs Revenue and Share by Players (2014-2019)
    3.2 Market Concentration Rate
        3.2.1 Top 5 Psoriasis Drugs Players Market Share
        3.2.2 Top 10 Psoriasis Drugs Players Market Share
    3.3 Market Competition Trend
4 Global Psoriasis Drugs Market Size by Regions
    4.1 Global Psoriasis Drugs Revenue and Market Share by Regions
    4.2 North America Psoriasis Drugs Revenue and Growth Rate (2014-2019)
    4.3 Europe Psoriasis Drugs Revenue and Growth Rate (2014-2019)
    4.4 Asia-Pacific Psoriasis Drugs Revenue and Growth Rate (2014-2019)
    4.5 South America Psoriasis Drugs Revenue and Growth Rate (2014-2019)
    4.6 Middle East and Africa Psoriasis Drugs Revenue and Growth Rate (2014-2019)
5 North America Psoriasis Drugs Revenue by Countries
    5.1 North America Psoriasis Drugs Revenue by Countries (2014-2019)
    5.2 USA Psoriasis Drugs Revenue and Growth Rate (2014-2019)
    5.3 Canada Psoriasis Drugs Revenue and Growth Rate (2014-2019)
    5.4 Mexico Psoriasis Drugs Revenue and Growth Rate (2014-2019)
6 Europe Psoriasis Drugs Revenue by Countries
    6.1 Europe Psoriasis Drugs Revenue by Countries (2014-2019)
    6.2 Germany Psoriasis Drugs Revenue and Growth Rate (2014-2019)
    6.3 UK Psoriasis Drugs Revenue and Growth Rate (2014-2019)
    6.4 France Psoriasis Drugs Revenue and Growth Rate (2014-2019)
    6.5 Russia Psoriasis Drugs Revenue and Growth Rate (2014-2019)
    6.6 Italy Psoriasis Drugs Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Psoriasis Drugs Revenue by Countries
    7.1 Asia-Pacific Psoriasis Drugs Revenue by Countries (2014-2019)
    7.2 China Psoriasis Drugs Revenue and Growth Rate (2014-2019)
    7.3 Japan Psoriasis Drugs Revenue and Growth Rate (2014-2019)
    7.4 Korea Psoriasis Drugs Revenue and Growth Rate (2014-2019)
    7.5 India Psoriasis Drugs Revenue and Growth Rate (2014-2019)
    7.6 Southeast Asia Psoriasis Drugs Revenue and Growth Rate (2014-2019)
8 South America Psoriasis Drugs Revenue by Countries
    8.1 South America Psoriasis Drugs Revenue by Countries (2014-2019)
    8.2 Brazil Psoriasis Drugs Revenue and Growth Rate (2014-2019)
    8.3 Argentina Psoriasis Drugs Revenue and Growth Rate (2014-2019)
    8.4 Colombia Psoriasis Drugs Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Psoriasis Drugs by Countries
    9.1 Middle East and Africa Psoriasis Drugs Revenue by Countries (2014-2019)
    9.2 Saudi Arabia Psoriasis Drugs Revenue and Growth Rate (2014-2019)
    9.3 UAE Psoriasis Drugs Revenue and Growth Rate (2014-2019)
    9.4 Egypt Psoriasis Drugs Revenue and Growth Rate (2014-2019)
    9.5 Nigeria Psoriasis Drugs Revenue and Growth Rate (2014-2019)
    9.6 South Africa Psoriasis Drugs Revenue and Growth Rate (2014-2019)
10 Global Psoriasis Drugs Market Segment by Type
    10.1 Global Psoriasis Drugs Revenue and Market Share by Type (2014-2019)
    10.2 Global Psoriasis Drugs Market Forecast by Type (2019-2024)
    10.3 Tumor Necrosis Factor Inhibitor Revenue Growth Rate (2014-2024)
    10.4 Interleukin Inhibitors Revenue Growth Rate (2014-2024)
    10.5 Others Revenue Growth Rate (2014-2024)
11 Global Psoriasis Drugs Market Segment by Application
    11.1 Global Psoriasis Drugs Revenue Market Share by Application (2014-2019)
    11.2 Psoriasis Drugs Market Forecast by Application (2019-2024)
    11.3 Topicals Revenue Growth (2014-2019)
    11.4 Systemic Revenue Growth (2014-2019)
    11.5 Biologics Revenue Growth (2014-2019)
12 Global Psoriasis Drugs Market Size Forecast (2019-2024)
    12.1 Global Psoriasis Drugs Market Size Forecast (2019-2024)
    12.2 Global Psoriasis Drugs Market Forecast by Regions (2019-2024)
    12.3 North America Psoriasis Drugs Revenue Market Forecast (2019-2024)
    12.4 Europe Psoriasis Drugs Revenue Market Forecast (2019-2024)
    12.5 Asia-Pacific Psoriasis Drugs Revenue Market Forecast (2019-2024)
    12.6 South America Psoriasis Drugs Revenue Market Forecast (2019-2024)
    12.7 Middle East and Africa Psoriasis Drugs Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
    14.1 Methodology
    14.2 Data Source

Related Categories
Pharmaceuticals
Related Reports
Global Tigecycline Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Tigecycline Market gives an estimation of the development of the market based on historical studies and also provides forecasts  read more..


Global Risperidone Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

The Global Risperidone Market Report is equipped with market data from 2015 to 2025. The report gives a market overview covering key drivers and risks  read more..


Global Caffeine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Caffeine Market gives an estimation of the development of the market based on historical studies and also provides forecasts on  read more..


Global Rabies Vaccine Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Rabies Vaccine Market gives an estimation of the development of the market based on historical studies and also provides  read more..


Global Radiopharmaceuticals Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Radiopharmaceuticals Market gives an estimation of the development of the market based on historical studies and also provides  read more..


Global Neurorehabilitation System Market Research Report

The report on the Global Neurorehabilitation System Market gives an estimation of the development of the market based on historical studies and also  read more..


Global Molecular Biology Kits And Reagents Market Research Report

The report on the Global Molecular Biology Kits And Reagents Market gives an estimation of the development of the market based on historical studies and  read more..


Global High Acuity Care Information Systems Market Research Report

The report on the Global High Acuity Care Information Systems Market gives an estimation of the development of the market based on historical studies and  read more..


Global Regenerative Medicine Market Research Report

The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013.   A number of factors such as increasing bone related  read more..


Global Skin Cancer Diagnostics Market Research Report

The report on the Global Skin Cancer Diagnostics Market gives an estimation of the development of the market based on historical studies and also  read more..